NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹20.31 | ₹20.85 | ₹18.43 | ₹-35.46 | ₹7.34 |
What is the latest Earnings Per Share (EPS) of NATH BIOGENES (INDIA) ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹20.31 |
| Mar2024 | ₹20.85 |
| Mar2023 | ₹18.43 |
| Mar2022 | ₹-35.46 |
| Mar2013 | ₹7.34 |
How is Earnings Per Share (EPS) of NATH BIOGENES (INDIA) Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹20.31 | -2.59 | |
| Mar2024 | ₹20.85 | 13.13 | |
| Mar2023 | ₹18.43 | Positive | |
| Mar2022 | ₹-35.46 | Negative | |
| Mar2013 | ₹7.34 | - | |
Compare Earnings Per Share (EPS) of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹288.9 Cr | 7.4% | -8.5% | -23.9% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,123.8 Cr | 1.7% | -0.5% | -21.3% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,999.1 Cr | -0.6% | -5.3% | 2.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,032.0 Cr | 8.4% | 8.2% | -14.7% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,021.7 Cr | -4.5% | -17.4% | -39.8% | Stock Analytics | |
| INDO US BIOTECH | ₹251.5 Cr | -2.3% | -6.5% | -56.1% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 7.4% |
-8.5% |
-23.9% |
| SENSEX | -0.5% |
1.1% |
3.8% |
You may also like the below Video Courses